Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy.
about
Sleep, death, and the heartIntermittent hypoxia: a low-risk research tool with therapeutic value in humansPeripheral chemoreception and arterial pressure responses to intermittent hypoxiaHypoxia-inducible factors and hypertension: lessons from sleep apnea syndromeSympathetic nervous system overactivity and its role in the development of cardiovascular diseasePathophysiology of sleep apneaSympathetic and catecholaminergic alterations in sleep apnea with particular emphasis on children.Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: role of the angiotensin II type 1 receptor.Upper airway function in the pathogenesis of obstructive sleep apnea: a review of the current literatureIs insulin the new intermittent hypoxia?Hyperoxia attenuates muscle sympathetic nerve activity following isocapnic hypoxia in humans.Hypoxia-induced vasodilation and effects of regional phentolamine in awake patients with sleep apnea.Effects of first-time overnight CPAP therapy for increasing the complexity of the patient's physiological system.Understanding the metabolic syndrome: a modeling perspectiveFunctional and structural changes in the brain associated with the increase in muscle sympathetic nerve activity in obstructive sleep apnoeaMechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxiaChemoreflexes, sleep apnea, and sympathetic dysregulationLong-term CPAP treatment partially improves the link between cardiac vagal influence and delta sleepVentricular arrhythmia and sleep-related breathing disorders.Heart rate responses to autonomic challenges in obstructive sleep apnea.Reversal of functional changes in the brain associated with obstructive sleep apnoea following 6 months of CPAPMild obstructive sleep apnea does not modulate baroreflex sensitivity in adult patientsBrain stem activity changes associated with restored sympathetic drive following CPAP treatment in OSA subjects: a longitudinal investigation.Blunted heart rate recovery is improved following exercise training in overweight adults with obstructive sleep apnea.Sympatho-adrenal activation by chronic intermittent hypoxia.Blood Pressure Increases in OSA due to Maintained Neurovascular Sympathetic Transduction: Impact of CPAP.Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndromeSleep-related changes in autonomic control in obstructive sleep apnea: a model-based perspective.Intrathecal Intermittent Orexin-A Causes Sympathetic Long-Term Facilitation and Sensitizes the Peripheral Chemoreceptor Response to Hypoxia in RatsHeart rate variability and muscle sympathetic nerve activity response to acute stress: the effect of breathing.Chronic intermittent hypoxia increases left ventricular contractility in C57BL/6J mice.Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome.Recent insights on circulating catecholamines in hypertension.Sleep Disordered Breathing: Hypertension and Cardiac Structure and Function.Sleep Disordered Breathing and the Pathogenesis of Atrial Fibrillation.Impact of obstructive sleep apnoea and intermittent hypoxia on cardiovascular and cerebrovascular regulation.Obstructive Sleep Apnea and Vascular Diseases.Model-Derived Markers of Autonomic Cardiovascular Dysfunction in Sleep-Disordered Breathing.The effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia.Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure.
P2860
Q26799361-013C321C-C130-4F15-85D3-A4B3256503E1Q26824915-CCFBCE04-64C4-4F48-8B5A-EB64F71BDE0CQ26996367-340C644E-0B0F-4EFB-A83B-4258B18C5A70Q27026931-C43F66AE-1C58-489F-984D-D894293BDD36Q28279754-4B408953-AFCA-4D72-BD00-A0CF5520B79DQ30440658-B3FB9A10-2AE5-44F0-8CB4-7344EB119037Q30470637-16F34296-F7EA-434F-A205-B5DF4971E28DQ30475820-316677C8-B8BD-4BF4-85DC-3B8D5FD1B943Q30485569-BE82A3FB-EA63-4E2B-BDE9-95A933D32531Q33622116-D016C87A-FFA4-470E-AAE8-3EA302924D51Q33783461-33A8B15E-260A-4632-8519-37133EE205B7Q33841102-1615C99E-F2C1-45FB-9B87-4C9269DC01BCQ34029688-F0FB97BF-1BBF-487A-AFEB-E1C736FB9CACQ34129723-6E8266B4-B876-40C4-A27E-334427984480Q34432300-A058F15D-E4F8-4103-9627-221B9651C469Q34591791-85E01C22-1555-412B-AAC2-C4A8BBB9F4A4Q34598170-08259F59-4C78-4598-BDBC-8C544B084D56Q34694569-CC6C0E5C-D858-4E29-B4F6-056BA48016E2Q34851567-99E5FC02-C356-4037-8EFB-8F3A1F13378FQ35032310-377ED7B7-FEFC-469F-8770-66B01B1A74A6Q35693652-48D3C2F6-C227-4FE6-BC51-8711836D5A6AQ35803897-49FF81AC-DC47-45ED-8813-55F61A8E719FQ35942622-33A82F4A-607C-41E3-99EC-F60B51A12B13Q36157774-580E1C39-04F4-40C9-A93B-7A0AA9D5494CQ36320908-A71E8EFB-295B-4243-AE84-F8643357778FQ36340657-C4E33D88-7B35-4E8E-905A-47D2A8615404Q37015491-5374FA63-50D7-48AF-9415-477EEE298A88Q37185178-58D23D44-6700-42E6-B38E-AEA0FBD1D827Q37206275-A69E29FA-3618-45F9-933A-C653084C37CDQ37245698-EE45A839-C3BE-45FE-B7BB-B2ACE8F9951FQ37372426-B7514474-57A4-4432-91F5-DB68BF21D4D1Q38256622-E06A5566-1BB9-43DF-93BA-80F0E15DB2EFQ38258965-90B73222-1148-4FC1-B0AF-979D3E26EA62Q38614181-C7C19DB8-D40C-4D92-BEF6-3F254928C557Q38790441-8449CB5A-45BE-4858-B00D-0DDA15BFC18EQ38821538-311181D2-830B-4C0B-9895-D620711527EEQ38878249-C48FDD32-57E8-4AF9-9FA8-3E8A057205EAQ39101456-32DBDB2F-5702-4C62-AE68-19BA9BA96679Q42082788-FC49F61F-3243-49A6-AC8C-BFB5FD27B5E0Q45770238-A0BD9184-BDCC-42D8-A02B-58F3A49FCC98
P2860
Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Sympathetic chemoreflex respon ...... itive airway pressure therapy.
@en
Sympathetic chemoreflex respon ...... itive airway pressure therapy.
@nl
type
label
Sympathetic chemoreflex respon ...... itive airway pressure therapy.
@en
Sympathetic chemoreflex respon ...... itive airway pressure therapy.
@nl
prefLabel
Sympathetic chemoreflex respon ...... itive airway pressure therapy.
@en
Sympathetic chemoreflex respon ...... itive airway pressure therapy.
@nl
P2093
P356
P1433
P1476
Sympathetic chemoreflex respon ...... itive airway pressure therapy.
@en
P2093
Cynthia S Hogeman
Kristen S Gray
Urs A Leuenberger
Virginia A Imadojemu
Zubina Mawji
P304
P356
10.1378/CHEST.06-2580
P407
P577
2007-05-01T00:00:00Z